Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$44.85 USD

44.85
775,431

+0.73 (1.65%)

Updated Sep 11, 2024 03:59 PM ET

After-Market: $45.07 +0.22 (0.49%) 5:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific

Quidel Enters Oversold Territory

Quidel has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Urmimala Biswas headshot

Coronavirus Test Makers With Scope to Maximize Investor Benefits

The surge in new coronavirus infections broadens the scope for antigen and antibody tests.

Omeros (OMER) Catches Eye: Stock Jumps 6%

Omeros (OMER) saw a big move last session, as its shares jumped 6% on the day, amid huge volumes.

Panel Of Zacks Experts headshot

Top Stock Picks for Week of September 8, 2020

Take a look at our expert's weekly picks which include Quidel (QDEL) and American Woodwork (AMWD).

Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?

Is (QDEL) Outperforming Other Medical Stocks This Year?

Surface Oncology (SURF) Looks Good: Stock Adds 9.8% in Session

Surface Oncology (SURF) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics

The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics

Urmimala Biswas headshot

Price War in Coronavirus Test Space to Intensify Thanks to Abbott

Most rapid antigen tests in the United States require an additional system, which is making the procedures more costly and complex.

Nalak Das headshot

7 Top-Ranked Corporate Giants With More Than 50% Return YTD

A handful of corporate giants (market capital > $10 billion) have skyrocketed this year, braving the pandemic and its impact on businesses.

Has Quidel (QDEL) Outpaced Other Medical Stocks This Year?

Is (QDEL) Outperforming Other Medical Stocks This Year?

Kevin Cook headshot

Bull of the Day: Quidel (QDEL)

Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply

Quidel's Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Quidel.

ICU Medical (ICUI) Looks Good: Stock Adds 8.1% in Session

ICU Medical (ICUI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

The Zacks Analyst Blog Highlights: Novava, Veritone, Kopin, Quidel and Unum Therapeutics

The Zacks Analyst Blog Highlights: Novava, Veritone, Kopin, Quidel and Unum Therapeutics

Encompass Health's (EHC) Expansion Plans Continue in Florida

Encompass Health (EHC) continues to expand in Florida via hospitals in order to offer improved health services in the state.

Grab These Stocks With Momentum Anomaly for Better Returns

These fast movers are currently witnessing a short-term pullback in price. So make sure you're making the most of this opportunity.

Sweta Killa headshot

Nasdaq Tops 11,000: 5 Best Stocks With Room for More Upside

On Aug 6, the Nasdaq Composite Index topped the milestone of 11,000. The tech-heavy laden completed its 1000-point journey in 40 trading days, representing the fastest ever rise in 20 years.

The Zacks Analyst Blog Highlights: Nautilus, Veritone, Quidel, DocuSign and Shopify

The Zacks Analyst Blog Highlights: Nautilus, Veritone, Quidel, DocuSign and Shopify

Sweta Killa headshot

5 Growth ETFs & Stocks to Ride the Market Rally

Growth investing has taken the lead over value and is likely to stay given a slew of reasons.

The Zacks Analyst Blog Highlights: PulteGroup, Quidel, D.R. Horton and West Pharmaceutical Services

The Zacks Analyst Blog Highlights: PulteGroup, Quidel, D.R. Horton and West Pharmaceutical Services

Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?

Is (QDEL) Outperforming Other Medical Stocks This Year?

Nalak Das headshot

Wall Street is Northbound Defying All Concerns: 5 Top Picks

A new bull market that was developed last quarter exiting the coronavirus-induced short bear market, is raging forward in the third quarter too.

Quidel (QDEL) Surpasses Q2 Earnings and Revenue Estimates

Quidel (QDEL) delivered earnings and revenue surprises of 66.07% and 0.18%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?